Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Insmed Inc shares valued at $96,682 were purchased by Bonstein Sara on Jan 08 ’25. At $66.04 per share, Bonstein Sara acquired 1,464 shares.
Also, Flammer Martina M.D. purchased 1,702 shares, netting a total of over 112,587 in proceeds.
Before that, Adsett Roger had added 1,882 shares to its account. In a trade valued at $124,400, the Officer bought Insmed Inc shares for $66.10 each.
As published in their initiating research note from Truist on April 23, 2024, Insmed Inc [INSM] has been a Buy and the price target has been revised to $48. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for INSM.
Analyzing INSM Stock Performance
During the last five days, there has been a drop of approximately -4.81%. Over the course of the year, Insmed Inc shares have dropped approximately -4.81%. Shares of the company reached a 52-week high of $70.75 on 01/03/25 and a 52-week low of $64.70 on 01/07/25. A 50-day SMA is recorded $71.28, while a 200-day SMA reached $61.11. Nevertheless, trading volume fell to 1.84 million shares from 2.14 million shares the previous day.
Support And Resistance Levels for Insmed Inc (INSM)
According to the 24-hour chart, there is a support level at 64.79, which, if violated, would cause prices to drop to 63.86. In the upper region, resistance lies at 66.58. The next price resistance is at 67.43. RSI (Relative Strength Index) is 33.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.95, which suggests the price will decrease in the coming days. Percent R is at 89.58%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
